Register
Login:
Share:
Email Facebook Twitter

London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis Watch Now

London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England




Share Price Information for Nuformix (NFX)


Share Price: 6.35Bid: 0.00Ask: 0.00Change: 0.00 (0.00%)No Movement on Nuformix
Spread: 0.00Spread as %: 0.00%Open: 6.65High: 0.00Low: 0.00Yesterday’s Close: 6.35

Nuformix Plc Ord 0.1P

Nuformix is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
6.35
Share Price SpacerBid
0.00
Share Price SpacerAsk
0.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
6.65
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
6.35
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 460.75m £29.26m 50,000

52 Week High 7.35 52 Week High Date 15-MAY-2019
52 Week Low 1.90 52 Week Low Date 12-FEB-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -12.959 -0.49 0.00 0.00


London South East Users info for Nuformix




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

17-May-19
16:29:48
6.44
13,767
Buy* 
6.20
6.50
886.59
Trade Type:
Ordinary

17-May-19
16:29:48
6.44
13,767
Buy* 
6.20
6.50
886.59
Trade Type:
Ordinary

17-May-19
16:24:51
6.449
48,833
Buy* 
6.20
6.50
3,149
Trade Type:
Ordinary




View more Nuformix trades >>

Directors Deals for Nuformix (NFX)
Trade DateActionNotifierPriceCurrencyAmountHolding
16-Aug-18Buy
Trade Notifier Information for Nuformix
Kirk Siderman-Wolte held the position of Non-Executive Director at Nuformix at the time of this trade.
 Kirk Siderman-Wolte
2.6GBX35,36435364
31-Mar-18Notification of Holding
Trade Notifier Information for Nuformix
David Tapolczay held the position of Non-Executive Chairman at Nuformix at the time of this trade.
 David Tapolczay
0045000000
31-Mar-18Notification of Holding
Trade Notifier Information for Nuformix
Daniel Gooding held the position of CEO at Nuformix at the time of this trade.
 Daniel Gooding
0037500000
View more Nuformix directors dealings >>


mornington-oz
Posts: 9,570
Opinion:No Opinion
Price:6.35
RE: results release
Today 06:47
Fingers crossed for a good week here. I’m hoping for a least 8-9p by Friday.
mornington-oz
Posts: 9,570
Opinion:No Opinion
Price:6.35
RE: results release
Today 06:41
That would give us a share price of around 20p?
happyholder
Posts: 4,445
Opinion:Strong Buy
Price:6.35
RE: results release
Today 06:35
reading your post AIM makes me wonder if that has been the delay in issuing broker name. they may have had to wait for us to get to 100m cap before they could take us on. Interesting GLA HH
Aim4Utopia
Posts: 5,623
Premium Chat Member
Opinion:No Opinion
Price:6.35
RE: results release
Today 06:32
I’ll be fascinated to see who the broker is as that will be a key indicator here. If it’s who I think it maybe then they won’t even take on a company less than £100 million MCAP. Very very interesting indeed.
Scaryone
Posts: 2,274
Opinion:Strong Buy
Price:6.35
RE: results release
Today 05:15
Let’s hope the results of the human trials are a mega success.... here’s to a hopefully mega week. Gla
View more share chat for Nuformix (NFX) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.